Brightspring health services specialty pharmacy onco360® selected as national pharmacy partner for voydeya®

Louisville, ky., april 10, 2024 (globe newswire) -- brightspring health services (“brightspring” or “brightspring health services”) (nasdaq: btsg) announced today that its company onco360®, a leading independent oncology pharmacy, was selected as a national pharmacy partner by alexion pharmaceuticals for a first-in-class, oral, factor d inhibitor, voydeya® (danicopan) to treat patients with a rare, life-threatening disease of the blood called paroxysmal nocturnal hemoglobinuria (pnh) who are experiencing extravascular hemolysis (evh).
BTSG Ratings Summary
BTSG Quant Ranking